contract development and manufacturing organization

  1. V

    Pharmaceutical Company Sai Parenteral IPO Sees Strong Performance

    New Delhi, April 2 Shares of Sai Parenteral, a diversified pharmaceutical formulation company, closed on Thursday with a premium of nearly 4 per cent against the issue price of Rs 392.The stock made its market debut at Rs 405, up 3.32 per cent from the issue price on the BSE. During the day...
  2. S

    Sai Parenteral IPO: 41% Subscription on Day 2

    New Delhi, March 25 The initial public offering of Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, saw 41 per cent subscription on the second day of the share sale on Wednesday.The IPO received bids for 30,82,788 shares against 75,22,486 shares on offer, according to...
  3. A

    Pharmaceutical IPO: Sai Parenteral's Initial Offering

    New Delhi, March 24 The initial public offering of Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, received 4% subscription on the first day of bidding on Tuesday.According to NSE data, the IPO received bids for 3,35,350 shares against 75,22,486 shares on offer.The...
Back
Top